230 related articles for article (PubMed ID: 12069813)
1. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction.
Xu Y
Biochim Biophys Acta; 2002 May; 1582(1-3):81-8. PubMed ID: 12069813
[TBL] [Abstract][Full Text] [Related]
2. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4.
Zhu K; Baudhuin LM; Hong G; Williams FS; Cristina KL; Kabarowski JH; Witte ON; Xu Y
J Biol Chem; 2001 Nov; 276(44):41325-35. PubMed ID: 11535583
[TBL] [Abstract][Full Text] [Related]
3. Sphingosylphosphorylcholine-biological functions and mechanisms of action.
Meyer zu Heringdorf D; Himmel HM; Jakobs KH
Biochim Biophys Acta; 2002 May; 1582(1-3):178-89. PubMed ID: 12069827
[TBL] [Abstract][Full Text] [Related]
4. G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine.
Murakami N; Yokomizo T; Okuno T; Shimizu T
J Biol Chem; 2004 Oct; 279(41):42484-91. PubMed ID: 15280385
[TBL] [Abstract][Full Text] [Related]
5. The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner.
Bektas M; Barak LS; Jolly PS; Liu H; Lynch KR; Lacana E; Suhr KB; Milstien S; Spiegel S
Biochemistry; 2003 Oct; 42(42):12181-91. PubMed ID: 14567679
[TBL] [Abstract][Full Text] [Related]
6. Lysophospholipids and ATP mutually suppress maturation and release of IL-1 beta in mouse microglial cells using a Rho-dependent pathway.
Takenouchi T; Iwamaru Y; Sugama S; Sato M; Hashimoto M; Kitani H
J Immunol; 2008 Jun; 180(12):7827-39. PubMed ID: 18523246
[TBL] [Abstract][Full Text] [Related]
7. Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands.
Kostenis E
J Cell Biochem; 2004 Aug; 92(5):923-36. PubMed ID: 15258916
[TBL] [Abstract][Full Text] [Related]
8. Sphingosylphosphorylcholine induces proliferation of human adipose tissue-derived mesenchymal stem cells via activation of JNK.
Jeon ES; Song HY; Kim MR; Moon HJ; Bae YC; Jung JS; Kim JH
J Lipid Res; 2006 Mar; 47(3):653-64. PubMed ID: 16339111
[TBL] [Abstract][Full Text] [Related]
9. Sphingosylphosphorylcholine as a novel calmodulin inhibitor.
Kovacs E; Liliom K
Biochem J; 2008 Mar; 410(2):427-37. PubMed ID: 17979830
[TBL] [Abstract][Full Text] [Related]
10. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1.
Xu Y; Zhu K; Hong G; Wu W; Baudhuin LM; Xiao Y; Damron DS
Nat Cell Biol; 2000 May; 2(5):261-7. PubMed ID: 10806476
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.
Kabarowski JH; Zhu K; Le LQ; Witte ON; Xu Y
Science; 2001 Jul; 293(5530):702-5. PubMed ID: 11474113
[TBL] [Abstract][Full Text] [Related]
12. Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor.
Jin Y; Damaj BB; Maghazachi AA
Eur J Immunol; 2005 Sep; 35(9):2699-708. PubMed ID: 16078278
[TBL] [Abstract][Full Text] [Related]
13. Previously postulated "ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms.
Tobo M; Tomura H; Mogi C; Wang JQ; Liu JP; Komachi M; Damirin A; Kimura T; Murata N; Kurose H; Sato K; Okajima F
Cell Signal; 2007 Aug; 19(8):1745-53. PubMed ID: 17462861
[TBL] [Abstract][Full Text] [Related]
14. Emerging roles of sphingosylphosphorylcholine in modulating cardiovascular functions and diseases.
Ge D; Yue HW; Liu HH; Zhao J
Acta Pharmacol Sin; 2018 Dec; 39(12):1830-1836. PubMed ID: 30050085
[TBL] [Abstract][Full Text] [Related]
15. Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation.
Mogi C; Tomura H; Tobo M; Wang JQ; Damirin A; Kon J; Komachi M; Hashimoto K; Sato K; Okajima F
J Pharmacol Sci; 2005 Oct; 99(2):160-7. PubMed ID: 16210776
[TBL] [Abstract][Full Text] [Related]
16. Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat.
Murch O; Abdelrahman M; Collino M; Gallicchio M; Benetti E; Mazzon E; Fantozzi R; Cuzzocrea S; Thiemermann C
Crit Care Med; 2008 Feb; 36(2):550-9. PubMed ID: 18216604
[TBL] [Abstract][Full Text] [Related]
17. Sphingosylphosphorylcholine enhances calcium entry in thyroid FRO cells by a mechanism dependent on protein kinase C.
Afrasiabi E; Blom T; Ekokoski E; Tuominen RK; Törnquist K
Cell Signal; 2006 Oct; 18(10):1671-8. PubMed ID: 16490345
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine.
Hemmings DG
Naunyn Schmiedebergs Arch Pharmacol; 2006 Apr; 373(1):18-29. PubMed ID: 16570136
[TBL] [Abstract][Full Text] [Related]
19. GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine.
Kim KS; Ren J; Jiang Y; Ebrahem Q; Tipps R; Cristina K; Xiao YJ; Qiao J; Taylor KL; Lum H; Anand-Apte B; Xu Y
FASEB J; 2005 May; 19(7):819-21. PubMed ID: 15857892
[TBL] [Abstract][Full Text] [Related]
20. Bioactive lysophospholipids and mesangial cell intracellular signaling pathways: role in the pathobiology of kidney disease.
Kamanna VS; Bassa BV; Ganji SH; Roh DD
Histol Histopathol; 2005 Apr; 20(2):603-13. PubMed ID: 15736064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
